|
1
|
Alam SR, Lewis SC, Zamvar V, Pessotto R,
Dweck MR, Krishan A, Goodman K, Oatey K, Harkess R, Milne L, et al:
Perioperative elafin for ischaemia-reperfusion injury during
coronary artery bypass graft surgery: A randomised-controlled
trial. Heart. 101:1639–1645. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Saat TC, van den Akker EK, IJzermans JN,
Dor FJ and de Bruin RW: Improving the outcome of kidney
transplantation by ameliorating renal ischemia reperfusion injury:
Lost in translation? J Transl Med. 14:202016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de Carvalho AL, Vital RB, Kakuda CM, Braz
JR, Castiglia YM, Braz LG, Módolo MP, Ribeiro OR, Domingues MA and
Módolo NS: Dexmedetomidine on renal ischemia-reperfusion injury in
rats: Assessment by means of NGAL and histology. Ren Fail.
37:526–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kumar S, Allen DA, Kieswich JE, Patel NS,
Harwood S, Mazzon E, Cuzzocrea S, Raftery MJ, Thiemermann C and
Yaqoob MM: Dexamethasone ameliorates renal ischemia-reperfusion
injury. J Am Soc Nephrol. 20:2412–2425. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hussein AM, Harraz AM, Awadalla A, Barakat
N, Khater S and Shokeir AA: Remote limb ischemic preconditioning
(rIPC) activates antioxidant and antiapoptotic genes and inhibits
proinflammatory cytokine genes in renal ischemia/reperfusion
injury. Gen Physiol Biophys. 35:77–86. 2016.PubMed/NCBI
|
|
6
|
Pan X, Wang J, Pu Y, Yao J and Wang H:
Effect of puerarin on expression of ICAM-1 and TNF-α in kidneys of
diabetic rats. Med Sci Monit. 21:2134–2140. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun J, Zhu Y, Zhang L and Ma Y: Effects of
xuelian injection on cerebral TNF-α, IL-1β and MMP-9 in rats
experienced focal cerebral ischemia/reperfusion. Int J Clin Exp
Med. 7:2632–2638. 2014.PubMed/NCBI
|
|
8
|
Xin L, Hou Q, Xiong QI and Ding X:
Association between matrix metalloproteinase-2 and matrix
metalloproteinase-9 polymorphisms and endometriosis: A systematic
review and meta-analysis. Biomed Rep. 3:559–565. 2015.PubMed/NCBI
|
|
9
|
Kato H, Duarte S, Liu D, Busuttil RW and
Coito AJ: Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances
MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic
Ischemia and Reperfusion Injury in Mice. PLoS One. 10:e01376422015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang R, Zhou Q, Veeraragoo P, Yu H and
Xiao Z: Notch2/Hes-1 pathway plays an important role in renal
ischemia and reperfusion injury-associated inflammation and
apoptosis and the γ-secretase inhibitor DAPT has a nephroprotective
effect. Ren Fail. 33:207–216. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garcia-Cenador MB, Lorenzo-Gomez MF,
Herrero-Payo JJ, Ruiz J, de Perez Obanos MP, Pascual J, Lopez-Novoa
JM and Garcia-Criado FJ: Cardiotrophin-1 administration protects
from ischemia-reperfusion renal injury and inflammation.
Transplantation. 96:1034–1042. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Si Y, Bao H, Han L, Shi H, Zhang Y, Xu L,
Liu C, Wang J, Yang X, Vohra A and Ma D: Dexmedetomidine protects
against renal ischemia and reperfusion injury by inhibiting the
JAK/STAT signaling activation. J Transl Med. 11:1412013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang GH, Yang HY, Zhang JC, Ren JJ, Sang
XT, Lu X, Zhong SX and Mao YL: Magnesium isoglycyrrhizinate
inhibits inflammatory response through STAT3 pathway to protect
remnant liver function. World J Gastroenterol. 21:12370–12380.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xie C, Li X, Wu J, Liang Z, Deng F, Xie W,
Zhu M, Zhu J, Zhu W, Geng S and Zhong C: Anti-inflammatory activity
of magnesium isoglycyrrhizinate through inhibition of phospholipase
A2/Arachidonic acid pathway. Inflammation. 38:1639–1648. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen KJ, Chen WY, Chen X, Jia YM, Peng GQ
and Chen L: Increased elimination of paclitaxel by magnesium
isoglycyrrhizinate in epithelial ovarian cancer patients treated
with paclitaxel plus cisplatin: A pilot clinical study. Eur J Drug
Metab Pharmacokinet. 39:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang X, Qin J and Lu S: Magnesium
isoglycyrrhizinate protects hepatic L02 cells from
ischemia/reperfusion induced injury. Int J Clin Exp Pathol.
7:4755–4764. 2014.PubMed/NCBI
|
|
17
|
Sureshkumar KK, Hussain SM, Ko TY, Thai NL
and Marcus RJ: Effect of high-dose erythropoietin on graft function
after kidney transplantation: A randomized, double-blind clinical
trial. Clin J Am Soc Nephrol. 7:1498–1506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmiedt CW, Mercurio AD, Glassman MM,
McAnulty JF, Brown CA and Brown SA: Effects of renal autograft
ischemia and reperfusion associated with renal transplantation on
arterial blood pressure variables in clinically normal cats. Am J
Vet Res. 70:1426–1432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gaber AO, Mulgaonkar S, Kahan BD, Woodle
ES, Alloway R, Bajjoka I, Jensik S, Klintmalm GB, Patton PR,
Wiseman A, et al: YSPSL (rPSGL-Ig) for improvement of early renal
allograft function: A double-blind, placebo-controlled,
multi-center Phase IIa study. Clin Transplant. 25:523–533. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Snoeijs MG, van Bijnen A, Swennen E,
Haenen GR, Roberts LJ II, Christiaans MH, Peppelenbosch AG, Buurman
WA and van Ernest Heurn LW: Tubular epithelial injury and
inflammation after ischemia and reperfusion in human kidney
transplantation. Ann Surg. 253:598–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suyani E, Derici UB, Sahin T, Ofluoglu E,
Pasaoglu H, Erdem O, Barit G, Reis KA, Erten Y, Arinsoy T and
Sindel S: Effects of everolimus on cytokines, oxidative stress, and
renal histology in ischemia-reperfusion injury of the kidney. Ren
Fail. 31:698–703. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen HH, Chen TW and Lin H:
Prostacyclin-induced peroxisome proliferator-activated
receptor-alpha translocation attenuates NF-kappaB and TNF-alpha
activation after renal ischemia-reperfusion injury. Am J Physiol
Renal Physiol. 297:F1109–F1118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Li JH, Wang L, Han M, Xiao F, Lan
XQ, Li YQ, Xu G and Yao Y: Glucocorticoid receptor agonist
dexamethasone attenuates renal ischemia/reperfusion injury by
up-regulating eNOS/iNOS. J Huazhong Univ Sci Technolog Med Sci.
34:516–520. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zahmatkesh M, Kadkhodaee M, Arab HA and
Shams S: Effects of co-administration of an iNOS inhibitor wißth a
broad-spectrum reactive species scavenger in rat renal
ischemia/reperfusion injury. Nephron Exp Nephrol. 103:e119–e125.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ersoz N, Guven A, Cayci T, Uysal B, Turk
E, Oztas E, Akgul EO, Korkmaz A and Cetiner S: Comparison of the
efficacy of melatonin and 1400W on renal ischemia/reperfusion
injury: A role for inhibiting iNOS. Ren Fail. 31:704–710. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Phull H, Lien YH, Salkini MW, Escobar C,
Lai LW and Ramakumar S: Delivery of intercellular adhesion
molecule-1 antisense oligonucleotides using a topical hydrogel
tissue sealant in a murine partial nephrectomy/ischemia model.
Urology. 72:690–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Troncoso P, Ortiz AM, Domínguez J and
Kahan BD: Use of FTY 720 and ICAM-1 antisense oligonucleotides for
attenuating chronic renal damage secondary to ischemia-reperfusion
injury. Transplant Proc. 37:4284–4288. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hagar HH and El Tawab R Abd: Cysteinyl
leukotriene receptor antagonism alleviates renal injury induced by
ischemia-reperfusion in rats. J Surg Res. 178:e25–e34. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kłoda K, Domanski L, Pawlik A, Kurzawski
M, Safranow K and Ciechanowski K: Effect of the ICAM1 and VCAM1
gene polymorphisms on delayed graft function and acute kidney
allograft rejection. Ann Transplant. 15:15–20. 2010.PubMed/NCBI
|
|
30
|
Jain S, Bicknell GR and Nicholson ML:
Molecular changes in extracellular matrix turnover after renal
ischaemia-reperfusion injury. Br J Surg. 87:1188–1192. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kunugi S, Shimizu A, Kuwahara N, Du X,
Takahashi M, Terasaki Y, Fujita E, Mii A, Nagasaka S, Akimoto T, et
al: Inhibition of matrix metalloproteinases reduces
ischemia-reperfusion acute kidney injury. Lab Invest. 91:170–180.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao ZW, Zhang W, Ma L and Qiu ZW:
Therapeutic effect of magnesium isoglycyrrhizinate in rats on lung
injury induced by paraquat poisoning. Eur Rev Med Pharmacol Sci.
18:311–320. 2014.PubMed/NCBI
|
|
33
|
Yang N, Luo M, Li R, Huang Y, Zhang R, Wu
Q, Wang F, Li Y and Yu X: Blockage of JAK/STAT signalling
attenuates renal ischaemia-reperfusion injury in rat. Nephrol Dial
Transplant. 23:91–100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu A, Huang JJ, Jin XJ, Li JP, Tang YJ,
Huang XF, Cui HJ, Xu WH and Sun GB: Curcumin suppresses
invasiveness and vasculogenic mimicry of squamous cell carcinoma of
the larynx through the inhibition of JAK-2/STAT-3 signaling
pathway. Am J Cancer Res. 5:278–288. 2014.PubMed/NCBI
|
